Britannia Life Sciences Inc. BLAB
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -28.80% | 5.97% | 1,772.94% | -86.25% | -17.59% |
| Total Receivables | 33.33% | 102.77% | 88.48% | 45.06% | -6.87% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -19.47% | -31.24% | 435.87% | -2.13% | -44.71% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.76% | -1.79% | -74.91% | 0.97% | 4.17% |
| Total Current Assets | -24.27% | 8.77% | 468.41% | -63.59% | -13.41% |
|
|
|||||
| Total Current Assets | -24.27% | 8.77% | 468.41% | -63.59% | -13.41% |
| Net Property, Plant & Equipment | -19.33% | -17.89% | -14.02% | -14.16% | -5.63% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 2.30% | 6.27% | 117.29% | 2.96% | -10.96% |
|
|
|||||
| Total Accounts Payable | -25.08% | -60.93% | 148.60% | -5.36% | -32.51% |
| Total Accrued Expenses | -1.24% | -16.44% | -13.79% | 38.83% | -12.94% |
| Short-term Debt | 0.00% | -1.42% | 0.00% | -2.30% | 6.37% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -6.18% | -4.45% | 2.06% | -3.27% | 4.68% |
| Total Finance Division Other Current Liabilities | -1.71% | -- | -- | -- | -- |
| Total Other Current Liabilities | -1.71% | -- | -- | -- | -- |
| Total Current Liabilities | -12.66% | -41.22% | 60.83% | 11.95% | -23.80% |
|
|
|||||
| Total Current Liabilities | -12.66% | -41.22% | 60.83% | 11.95% | -23.80% |
| Long-Term Debt | -- | -- | -- | 39.14% | 4.35% |
| Short-term Debt | 0.00% | -1.42% | 0.00% | -2.30% | 6.37% |
| Capital Leases | -31.47% | -31.04% | -30.80% | -24.32% | -12.69% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -1.70% | -- | -- | -- | -- |
| Total Liabilities | -12.09% | -36.60% | -6.75% | 20.88% | -15.39% |
|
|
|||||
| Common Stock & APIC | -0.80% | -1.77% | 1.59% | -2.08% | 5.39% |
| Retained Earnings | 86.38% | 158.03% | 84.02% | -0.80% | -10.87% |
| Treasury Stock & Other | -5.91% | -6.11% | 3.26% | -6.23% | -12.58% |
| Total Common Equity | 4.46% | 18.29% | 246.52% | -10.83% | -7.22% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.46% | 18.29% | 246.52% | -10.83% | -7.22% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.46% | 18.29% | 246.52% | -10.83% | -7.22% |
|
|
|||||